268 completed, 35 unknown, 21 terminated, 15 not yet recruiting. 368 Phase 3, 68 Phase 2.
Follow Parasitic Diseases: new trials by email Literature Review of Parasitic Diseases trials Research Report on Parasitic Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| OPTIMAL LEAP: Optimizing Dihydroartemisinin-Piperaquine IPTsc Intervals to Advance Learning, Executive Function, Attendance, and Antimalarial Resistance Surveillance in Kenyan Schoolchildren Monthly DP, Quarterly DP - Malaria, Asymptomatic Malaria | Phase 3 | Not yet recruiting | Indiana University | 1500 | 2028-01-01 | 2026-09-01 |
| Follow-up Assessment of Change in Soil-transmitted Helminths Infection Intensity in Uganda Albendazole 400mg, Ivermectin 3 mg - Ascariasis | Phase 3 | Not yet recruiting | Jennifer Keiser | 450 | 2027-02-01 | 2026-11-17 |
| Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL) Sodium Stibogluconate (SSG), Miltefosine, Miltefosine + Paromomycin - Cutaneous Leihmaniasis | Phase 3 | Not yet recruiting | Institute of Tropical Medicine, Belgium | 900 | 2027-01-01 | 2026-03-10 |
| Nitazoxanide for Treatment of Cryptosporidium in Children Nitazoxanide, Placebo - Cryptosporidiosis | Phase 3 | Not yet recruiting | Johns Hopkins Bloomberg School of Public Health | 480 | 2026-12-30 | 2026-09-28 |
| Oxfendazole in Mild Parenchymal Brain Cysticercosis Oxfendazole single dose, Oxfendazole three doses, albendazole plus praziquantel regime - Brain Cysticercosis | Phase 2 / Phase 3 | Not yet recruiting | Universidad Peruana Cayetano Heredia | 544 | 2026-12-01 | 2026-05-01 |
| Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections emodepside (BAY 44-4400), Mebendazole 100 MG, similar placebo to mebendazole - Trichuris Trichiura; Infection, Hookworm Infection | Phase 3 | Not yet recruiting | Swiss Tropical & Public Health Institute | 315 | 2026-11-06 | 2026-08-14 |
| Different Treatment Frequencies for Hepatic Fibrosis Due to Schistosomiasis Praziquantel 40 mg/kg per dose given once annually, Praziquantel 40 mg/kg given three times per year - Schistosomiasis, Schistosoma Mansoni | Phase 2 / Phase 3 | Not yet recruiting | Rhode Island Hospital | 600 | 2026-11-01 | 2026-08-12 |
| Combination Therapies for Trichuris Trichiura Infection in Schoolchildren in Honduras Placebo, Albendazole 400 mg, Albendazole Plus Ivermectin - Trichuriasis, Strongyloidiasis | Phase 3 | Not yet recruiting | Mundo Sano Foundation | 368 | 2026-11-01 | 2026-06-23 |
| Better Options for Lymphatic Filariasis Treatment MoxDA - Moxidectin + Diethylcarbamzine (DEC) + Albendazole, IDA - Ivermectin + DEC + albendazole - Lymphatic Filariasis, Scabies | Phase 3 | Recruiting | Medicines Development for Global Health | 5100 | 2026-09-28 | 2026-10-07 |
| Efficacy of Diloxanide Furoate as Additional Luminal Agent Along With Metronidazole for the Treatment of Amoebic Liver Abscess Diloxanide furoate, Placebo - Liver Abscess, Amoebic Liver Abscess | Phase 3 | Not yet recruiting | Post Graduate Institute of Medical Education and Research, Chandigarh | 220 | 2026-09-04 | 2026-09-10 |
| An Ultra-short Course of Primaquine for the Radical Cure of Vivax Malaria High dose ultra short Primaquine, Placebo - Malaria | Phase 3 | Not yet recruiting | Menzies School of Health Research | 1019 | 2026-06-01 | 2026-03-12 |
| Postpartum 8-aminoquinoline Breast Milk Study Daily primaquine (0.5 mg/kg per day) for 14 days given with food food and water, Daily primaquine 1 mg/kg per day for 7 days given with food and water, Single-dose tafenoquine given with food and water to prevent gastrointestinal discomfort - Drug Pharmacokinetics in Healthy Volunteers | Phase 2 / Phase 3 | Not yet recruiting | Curtin University | 60 | 2026-04-01 | 2026-03-18 |
| Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis II. Arnica Tincture, Meglumine antimoniate. - Leishmaniasis, Cutaneous | Phase 3 | Recruiting | Universidad de Antioquia | 96 | 2026-03-11 | 2026-04-02 |
| Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections emodepside (BAY 44-4400), matching placebo of emodepside, Mebendazole - Trichuris Trichiura; Infection, Hookworm Infection | Phase 3 | Completed | Swiss Tropical & Public Health Institute | 315 | 2025-11-25 | 2026-10-08 |
| Safety of Antimalarials in the FIRst trimEster dihydroartemisinin-piperaquine (DP), Pyronaridine-artesunate (PA), Artemether-lumefantrine - Malaria, Pregnancy, Malaria, Antepartum | Phase 3 | Recruiting | Liverpool School of Tropical Medicine | 1510 | 2025-09-30 | 2025-11-19 |
| Real World Evaluation of an Albendazole-Ivermectin Coformulation Safety and Effectiveness Pre-screening Phase, Screenig Phase, Randomization - Soil-Transmitted Helminths | Phase 3 | Recruiting | Insud Pharma | 20000 | 2025-09-01 | 2025-09-15 |
| STI Testing to Enhance PrEP Use in Pregnancy Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis testing - PrEP Adherence, Sexually Transmitted Infections (STIs) | Phase 3 | Recruiting | Botswana Harvard AIDS Institute Partnership | 600 | 2025-06-18 | 2026-06-11 |
| Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar PvSeroTAT, Control - Malaria Vivax, Malaria Falciparum | Phase 3 | Recruiting | London School of Hygiene and Tropical Medicine | 19200 | 2025-05-12 | 2026-09-18 |
| Monoclonal Antibodies in Children With Severe Anaemia or Severe Malaria to Prevent Malaria After Hospital Discharge Antimalarial monoclonal antibodies, Dihydroartemisinin - Piperaquine (DP), Placebo mMAB - Malaria, Severe Malaria | Phase 3 | Active not recruiting | Liverpool School of Tropical Medicine | 398 | 2025-05-02 | 2026-08-05 |
| Antimicrobial Adjuvants to Revert the Imbalance of Skin Microbiota for Improved Outcomes of Complicated Cutaneous Leishmaniasis Treatment in Ethiopia Fusidic Acid, Vehicle cream - Leishmaniasis, Cutaneous | Phase 3 | Not yet recruiting | Institute of Tropical Medicine, Belgium | 180 | 2025-04-01 | 2024-11-19 |
Showing 20 of 368. Sign in to see all of them.
Malaria (169) · Malaria, Falciparum (60) · Leishmaniasis, Cutaneous (24) · Malaria, Vivax (22) · Scabies (14) · Anemia (13) · Chagas Disease (13) · Leishmaniasis, Visceral (13) · Schistosomiasis (10) · Lice Infestations (9) · Trypanosomiasis, African (9) · Elephantiasis, Filarial (8) · HIV Infections (8) · Trichuriasis (8) · Ancylostomiasis (7)
Infections (362) · Protozoan Infections (291) · Vector Borne Diseases (289) · Mosquito-Borne Diseases (212) · Euglenozoa Infections (66) · Skin and Connective Tissue Diseases (59) · Skin Diseases (58) · Skin Diseases, Infectious (58) · Skin Diseases, Parasitic (58) · Helminthiasis (52) · Malaria (37) · Leishmaniasis (35) · Nematode Infections (31) · Secernentea Infections (29)
fanasil, pyrimethamine drug combination (40) · Artemether, Lumefantrine Drug Combination (36) · Albendazole (29) · Chloroquine (28) · Ivermectin (25) · Primaquine (21) · Amodiaquine (19) · Artesunate (19) · Praziquantel (14) · miltefosine (14) · Azithromycin (13) · Meglumine Antimoniate (12) · Paromomycin (11) · amodiaquine, artesunate drug combination (11) · pyronaridine tetraphosphate, artesunate drug combination (11)
London School of Hygiene and Tropical Medicine (53) · Drugs for Neglected Diseases (14) · University of Oxford (14) · Institute of Tropical Medicine, Belgium (12) · University of California, San Francisco (12) · GlaxoSmithKline (11) · Menzies School of Health Research (8) · Liverpool School of Tropical Medicine (7) · Jennifer Keiser (6) · Medicines for Malaria Venture (6) · Pfizer (6) · Makerere University (5) · National Institute of Allergy and Infectious Diseases (NIAID) (5) · Oswaldo Cruz Foundation (5) · Barcelona Institute for Global Health (4)
Uganda (36) · Kenya (34) · Burkina Faso (32) · Tanzania (28) · Brazil (26) · Ghana (22) · United States (21) · Democratic Republic of the Congo (20) · Mali (19) · India (18) · Ethiopia (14) · The Gambia (14) · Colombia (13) · Côte d’Ivoire (11) · Malawi (11)
Grant Dorsey, MD, PhD (6) · Diane V Havlir, MD (4) · Brian Greenwood, FRCP, FRS (3) · Brian Greenwood, MD (3) · Eric Ottesen, MD (3) · Jayaram Menon, MBBS (3) · Nigel Hill, PhD (3) · Paul J Milligan, PhD (3) · Shyam Sundar, MD (3) · Tsin Yeo, MBBS (3) · Alassane Dicko, Professor (2) · Arjen Dondorp, MD (2) · Armando O. Schubach, MD, PhD (2)
PMID 39324693, PMID 23433102, PMID 26666916, PMID 11873261, PMID 22610930, PMID 32228663, PMID 10656038, PMID 17845167, PMID 21849081, PMID 22993389, PMID 25425434, PMID 28379954, PMID 29324864, PMID 29547881, PMID 33020153, PMID 35732155, PMID 36534705, PMID 8937280, PMID 9790423, PMID 11500748, PMID 12095806, PMID 12510893, PMID 16235350, PMID 16503464, PMID 16551365, PMID 16640611, PMID 16702588, PMID 17046467, PMID 17128343, PMID 17239256, PMID 17519409, PMID 17519410, PMID 17582067, PMID 17940319, PMID 17958887, PMID 17971864, PMID 18074034, PMID 18171245, PMID 18213379, PMID 18237394, PMID 18414647, PMID 18495737, PMID 18522503, PMID 18547415, PMID 18547416, PMID 18582194, PMID 18598190, PMID 18620950, PMID 18682739, PMID 18752443
P01HD059454 (2), 2008 (1), 2009 (1), 2016 (1), 2019 (1), 2023 (1), R01AI104702 (1), R01AI155739 (1), R01AI184979 (1), R01NS054805 (1), U01AI126610 (1), U01AI138910 (1), U01AI155325 (1), U01AI157962 (1), U01AI167788 (1)